December 19, 2023
Philips-owned BioTelemetry Inc. and its subsidiary will pay over $14.7 million to settle False Claims Act allegations that they inflated federal healthcare reimbursements for six years by inducing providers to bill for cardiac telemetry instead of the cheaper cardiac event monitoring services doctors had intended, the U.S. Department of Justice announced Monday.